feed,title,long_url,short_url
MarketWatch,Biohaven's stock jumps 12% after saying its migraine drug had $93 million in sales in Q2,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/skytSJDVNq0/story.aspx,https://on.mktw.net/3dTDYff
